- ES
- EN
14th National Research Competition in Life and Earth Sciences
Rare diseases
Senior Researcher : Paloma Pérez Sánchez
Research Centre or Institution : Instituto de Biomedicina de Valencia. CSIC.
Ectodermic Dysplasias (EDs) comprise a large and heterogeneous group of congenital diseases that originate as a consequence of alterations in the development of embryonic ectodermic epithelia, after which it is named. ED patients have primary defects that affect the formation of hair, nails, teeth and sweat glands. In the most severe cases, the absence of sweat glands causes hypothermia in new-born babies and is considered a possible cause of sudden infant death syndrome. Even in those cases in which the patient's life is not at stake, the defects in dental and palate development, among others, require frequent surgical operations, which affects the quality of life of the patient and family members. To date, the causal gene has only been identified in thirty of the approximately two hundred pathologies classified as ED.
Our study proposes that the glucocorticoid (GR) receptor, a protein that controls hormone activity, plays a direct or indirect role in ED pathology, based on the known teratogenic effect of corticoids. Previous studies carried out by the group have demonstrated, by means of the generation and characterisation of genetically manipulated animal models, that GR overexpression in epithelia causes several morphogenetic defects, similar to the medical profile of ED patients. Therefore, by analysing different transgenic models of GR gain- and loss-of-function in epithelia, we will undertake to identify other underlying signalling pathways in these diseases. This study has potential application in the study of ED Syndrome, both in the possible early diagnosis of the disease and in treatment of epithelial damage in patients.
Activities related
Projects related
News related
Publications related
International Symposium Understanding and reprogramming developmental visual disorders: from anophthalmia to cortical impairments Madrid, Thursday and Friday, 30 and 31 January 2020, 9:30 hours
Panel Discussion Mundo de las prótesis, los nuevos materiales, sus complicaciones y su futuro Madrid , Lunes, 8 de abril 2024. 17.00 horas
Session Situación actual de las Enfermedades Raras en España Madrid, Martes, 23 de abril de 2024, 10:00 horas


La Fundación Ramón Areces refuerza su compromiso con las enfermedades raras
Published on 04/23/2024